6-(Trifluoromethoxy)-2-benzothiazolamine 2-氨基-6-三氟甲氧基苯并噻唑

CAS 1744-22-5 MFCD00210213

化学结构图

1744-22-5
SMILES: Nc1nc2ccc(OC(F)(F)F)cc2s1

化学属性

Mol. FormulaC8H5F3N2OS
Mol. Weight234
Melting Point116.0 to 120.0 deg-C
TSCANo
SolubilityDMSO 47 mg/mL Water <1 mg/mL Ethanol 47 mg/mL

别名和识别编码

Chemical Name6-(Trifluoromethoxy)-2-benzothiazolamine
CAS Number1744-22-5
Alfabeta NameAMINOTRIFLUOROMETHOXYBENZOTHIAZOLE 26()---
MDL NumberMFCD00210213
Synonym 2 Amino 6 trifluoromethoxybenzothiazole 2-Amino-6-(trifluoromethoxy)benzothiazole; 6-Trifluoromethoxy-2-aminobenzothiazole; 6-(Trifluoromethoxy)-1,3-benzothiazol-2-amine 2-Amino-6-trifluoromethoxybenzothiazole 2-Benzothiazolamine, 6-(trifluoromethoxy)- 2-​Amino-​6-​(trifluoromethoxy)​benzothiazole 6-(Trifluoromethoxy)-2-benzothiazolamine 6-(Trifluoromethoxy)benzothiazol-2-amine Amino-2 trifluoromethoxy-6 benzothiazole PK 26124 PK-26124 PK26124 RP 54274 RP-54274 RP54274 Rilutek Riluzole 利鲁唑;2-氨基-6-(三氟甲氧基)苯并噻唑
PubChem Substance ID5070
Chemical Name Translation2-氨基-6-三氟甲氧基苯并噻唑
Reaxys-RN748759
Merck Number8223
LabNetwork Molecule IDLN00110713
InChIInChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • Pharmaceuticals
  • Inhibitors
  • {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Excitatory Amino Acids, Neuroscience, Neurotransmission, Neurotransmitters, Other Excitatory Amino Acids, R, Sanofi Aventis, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
  • Sulfur & Selenium Compounds
  • Heterocycles
  • {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Cell Signaling and Neuroscience, Excitatory Amino Acids, Neuroscience, Neurotransmission, Neurotransmitters, Others, R, Sanofi Aventis, 细胞生物学
  • {SNA} Approved Therapeutics/Drug Candidates,

产品应用

  • A neuroprotective agent. Modulates glutamatergic transmission. A glutamate release inhibitor. An anticonvulsant.

相关文献及参考

  • Mizoule, J., et al.: Neuropharmacology, 24, 767 (1985),

安全信息

Warnings TOXIC
GHS Symbol
Precautionary statements
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
  • P301+P310
  • P301+P310+P330
  • P321 Specific treatment (see … on this label). 具体治疗(见本标签上的)。
  • P330 Rinse mouth. 漱口
  • P405 Store locked up. 上锁保管。
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
Hazard statements
  • H300 Fatal if swallowed 吞食致命
  • H301 Toxic if swallowed 吞食有毒
WGK Germany3
Signal word
RTECSDL2830000
Personal Protective Equipment Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
Hazard Codes T
Safety Statements
  • S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
  • S60 This material and its container must be disposed of as hazardous waste 该物质及其容器必须作为危险废物处置;
  • S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
  • S36/37/39 Wear suitable protective clothing, gloves and eye/face protection 穿戴适当的防护服、手套和眼睛/面保护;
  • S20 When using do not eat or drink 使用时,不得进食,饮水;
Risk Statements
UN Number 2811
Packing GroupII
Storage condition 储存温度-20°C
Hazard Class6.1
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 67 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
   Foreign Patents, Washington, DC 20231)  Volume(issue)/page/year: #50551

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 46 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   EPXXDW European Patent Application. (U.S. Patent and Trademark Office,
   Foreign Patents, Washington, DC 20231)  Volume(issue)/page/year: #50551

其他信息

  • Riluzole
  • Riluzole用于治疗肌萎缩性侧索硬化症。

系列性分类


相关产品推荐